Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
While everyone else is focused on a ‘tradable bounce’ in the S&P, with others in a freak-out on gold, back at the ranch, biotech has continued to sub-divide lower, getting weaker and weaker, still.
Note: All trades presented on this site during 2024 (ex: UNG), and 2025, have been to the short side (not advice, not a recommendation).
Biotech XBI, Weekly
The chart highlights the Fibonacci retrace levels.
A Fibonacci 23.6%, retrace is rare; markets typically like to go to 38.2%, or 50%.
If this retrace holds, it indicates significant weakness in the sector (not advice, not a recommendation).
As can been seen in the side-bar, current biotech short is LABD-25-03, with stop at yesterday’s LABD, session low (not advice, not a recommendation).
Not shown on the chart, a trading channel that appears to be in-effect.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The last time we had a major (sustained) economic melt-down, was 2007 – 2008.
The market (S&P) bottomed on March 9th, 2009, posting a low at 666.79.
During that collapse, Hartford Financial was one of the hardest hit.
It imploded, crashed, by -96.87%.
It’s important to note, HIG bottomed at 3.33, during the week-ending, 3/6/09; you can’t make this stuff up. 🙂
So, let’s take a look at what HIG, is doing now and if it’s at risk, yet again (not advice, not a recommendation).
We’re looking at the long-term, the Quarterly Chart
Hartford Financial, HIG, Quarterly
With just a few weeks left in the Quarter, HIG is positing a reversal.
From a classical analysis standpoint, a reversal back into the wedge (and then upside test) would be a potential sell-signal (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
From a price action standpoint, we have an outside down weekly bar as well as (potential) monthly reversal.
Despite fever-pitch, ‘the world’s ending’ talk on gold and (supposed) silver breakouts, we’re reminded here (time stamp 3:10) to expect a downward spike in gold should there be (serious) international trouble (not advice, not a recommendation).
Newmont’s the largest cap in the GDX; let’s take a look at the sector.
Senior Miners, GDX, Weekly
GDX, in the same vein as IWM, NVDA, SOXX, SPY, and TLT (to name a few), posting its own terminating wedge.
Noted in the chart, GDX has entered back into the wedge formation after a ‘throw-over’; typically, a bearish sign (not advice, not a recommendation).
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
For the mining sector we’re about to find out if it’s bulls or bears.
With today’s overall (S&P, Dow, QQQ, etc.) down market and the press screaming in hysterical panic at the start of the day, you’d think the market had collapsed 50% or more.
The last update (over the weekend) had this to say about the S&P (emphasis added):
“So, here we are: The market (SPY) has rallied over the past week, giving the illusion that all is well.
However, it too is now in up-thrust (reversal) position.“
So, the SPY declines by just over 1%, everyone loses their head and starts talking about CBDC.
Moving on to the ‘knee-jerk’ sector for the day, let’s look at the miners and specifically GDXJ.
Junior Miners GDXJ, Daily Close
Admittedly, the prior update was unsure whether or not this sector had its up-thrust reversal ‘test’.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
One report covering the historic narrowing of the market is here.
Never before seen narrow breadth: What does it mean?
It means the market’s ‘keeping up appearances’ while the foundation’s been removed.
That way, the professionals can get out the door; sell or sell-short, funnel capital to the only three tickers left (AAPL, AMZN, MSFT), while the public looks at the SPY, and says ‘Where’s the collapse?’
Let the crowd focus on the S&P … probably the most computer controlled, AI driven, Machiavellian manipulated market in the world … but hey, I’ve got my i-phone trading app and I’m going to ‘Put it to the man’.
Meanwhile, downside leader biotech, inches lower.
Biotech SPBIO, Daily
Let’s review where we are with SPBIO, with the full understanding that anything can happen.
For now, we’re heading lower (not advice, not a recommendation).
It’s obvious. Biotech’s following a Fibonacci time sequence.
Let’s pull out to the larger weekly chart and see something really scary.
Biotech SPBIO, Weekly Close
If we really are at the right side of the trading channel, it’s not looking good for the bulls.
Of course, it all makes sense.
The market’s at record breadth divergence. Banks are collapsing, Ukraine (fabricated, or not) coupled with trade wars, the consumer’s tapped-out (credit at maximum) and on it goes.
Positioning
Early this session, the short position in biotech (via LABD) was increased (not advice, not a recommendation).
The table below shows the trading (entry) activity during the on-going reversal (not advice, not a recommendation).
Hard Stop: 16.79
The notation ‘LABD-23-05’, indicates this is the fifth trading campaign (or trade series) in LABD for the year.
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.